Board of Directors
Michelle Welborn, PharmD
President
Lewisville, NC’
Peter Haeberli, JD
Counsel, Merk
Betsy English, MD
Winston Salem NC …
Michelle Welborn, PharmD
Michelle Welborn holds a Doctor of Pharmacy degree from Campbell University School of Pharmacy. She serves as President and CEO of Bravo Pharmaceuticals, a small start-up biotech company that will provide novel pharmaceuticals and first to market generic products for rare diseases, including intractable childhood epilepsy.
Peter Haeberli, JD
Peter Haeberli, J.D. joined Merck following the acquisition of Sirna Therapeutics Inc. in 2006. At Sirna, Mr. Haeberli held the position of Director, Intellectual Property, where he was instrumental in the development of the company’s intellectual property estate.